Ken Griffin Pmv Pharmaceuticals, Inc. Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 400 shares of PMVP stock, worth $696. This represents 0.0% of its overall portfolio holdings.

Number of Shares

400

Previous 1,900 78.95%

Holding current value

$696

Previous $3,000 100.0%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.51 - $2.21 $205,245 - $300,392	135,924 Added 8.6%	1,716,474 $2.78 Million
Q1 2024 May 15, 2024	BUY	$1.51 - $3.12 $528,802 - $1.09 Million	350,200 Added 28.46%	1,580,550 $2.69 Million
Q4 2023 Feb 14, 2024	SELL	$1.23 - $6.6 $851,168 - $4.57 Million	-692,007 Reduced 36.0%	1,230,350 $3.81 Million
Q3 2023 Nov 14, 2023	SELL	$6.01 - $8.93 $1.23 Million - $1.83 Million	-204,464 Reduced 9.61%	1,922,357 $11.8 Million
Q2 2023 Aug 14, 2023	BUY	$3.94 - $6.27 $1.37 Million - $2.17 Million	346,717 Added 19.48%	2,126,821 $13.3 Million
Q1 2023 May 15, 2023	BUY	$4.77 - $9.16 $1.93 Million - $3.7 Million	404,005 Added 29.36%	1,780,104 $8.49 Million
Q4 2022 Feb 14, 2023	BUY	$8.17 - $12.95 $3.32 Million - $5.27 Million	406,601 Added 41.94%	1,376,099 $12 Million
Q3 2022 Nov 14, 2022	SELL	$11.4 - $17.18 $5.02 Million - $7.57 Million	-440,580 Reduced 31.25%	969,498 $11.5 Million
Q2 2022 Aug 15, 2022	BUY	$9.23 - $22.43 $12.6 Million - $30.7 Million	1,369,096 Added 3340.73%	1,410,078 $20.1 Million
Q1 2022 May 16, 2022	SELL	$14.86 - $23.55 $1.78 Million - $2.82 Million	-119,570 Reduced 74.47%	40,982 $853,000
Q4 2021 Feb 14, 2022	BUY	$19.99 - $30.24 $2.7 Million - $4.09 Million	135,205 Added 533.42%	160,552 $3.71 Million
Q3 2021 Nov 15, 2021	SELL	$26.84 - $36.58 $2.72 Million - $3.71 Million	-101,288 Reduced 79.98%	25,347 $755,000
Q2 2021 Aug 16, 2021	BUY	$28.01 - $36.01 $3.27 Million - $4.2 Million	116,602 Added 1162.18%	126,635 $4.33 Million
Q1 2021 May 17, 2021	BUY	$30.66 - $49.5 $118,899 - $191,961	3,878 Added 63.01%	10,033 $330,000
Q4 2020 Feb 16, 2021	SELL	$31.86 - $61.51 $230,029 - $444,102	-7,220 Reduced 53.98%	6,155 $379,000
Q3 2020 Nov 16, 2020	BUY	$35.5 - $38.0 $474,812 - $508,250	13,375 New	13,375 $475,000

Others Institutions Holding PMVP

# of Institutions

Shares Held

43.7M

Call Options Held

500

Put Options Held

100

View Full List

About PMV Pharmaceuticals, Inc.

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $79.4M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

More about PMVP

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account